HMG-CoA reductase
17 drugs CardiovascularMetabolic
11
approved indications
17
Approved Drugs
17
Companies
20
Indications
2
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (17 companies)
✓ All 17 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (20 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
UPJOHN 1 drug
CMP DEV LLC 1 drug
PHARMOBEDIENT 1 drug
By Therapeutic Area
Cardiovascular 9 drugs
Metabolic 4 drugs
Drugs by Company PRO
UPJOHN 1 drug
CMP DEV LLC 1 drug
PHARMOBEDIENT 1 drug
RISING 1 drug
PHARMACIA 1 drug
SALERNO PHARMS 1 drug
ZHEJIANG JINGXIN 1 drug
AstraZeneca 1 drug
Merck 1 drug
Viatris 1 drug
+ 7 more companies
By Therapeutic Area
Cardiovascular 9 drugs
LIPITOR, ATORVALIQ, LYPQOZET, SIMVASTATIN +5 more
Metabolic 4 drugs
ROSUVASTATIN CALCIUM, CRESTOR, VYTORIN, ZYPITAMAG
Other 4 drugs
PITAVASTATIN CALCIUM, LIVALO, PRAVASTATIN SODIUM, ATORVASTATIN CALCIUM
Indications Treated
HypertensionCoronary Artery DiseaseCardiovascular DiseaseHyperlipidemiaPrimary HyperlipidemiaHeterozygous Familial HypercholesterolemiaAtherosclerosisHomozygous Familial HypercholesterolemiaPrimary DysbetalipoproteinemiaHypertriglyceridemiaMyocardial InfarctionStrokeAnginaType 2 DiabetesCoronary Heart DiseaseCongestive Heart FailureCerebrovascular DiseasePeripheral Vascular DiseaseDiabetesCoronary Atherosclerosis
All Drugs Targeting HMG-CoA reductase
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| LIPITOR Top | UPJOHN | 1996 | 11 | Cardiovascular |
| ATORVALIQ Top | CMP DEV LLC | 2023 | 11 | Cardiovascular |
| LYPQOZET Top | PHARMOBEDIENT | 2017 | 10 | Cardiovascular |
| SIMVASTATIN | RISING | 2006 | 9 | Cardiovascular |
| CADUET | PHARMACIA | 2004 | 9 | Cardiovascular |
| FLOLIPID | SALERNO PHARMS | 2016 | 9 | Cardiovascular |
| ROSUVASTATIN CALCIUM | ZHEJIANG JINGXIN | 2016 | 6 | Metabolic |
| CRESTOR | AstraZeneca | 2003 | 6 | Metabolic |
| VYTORIN | Merck | 2004 | 6 | Metabolic |
| AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | Viatris | 2013 | 4 | Cardiovascular |
| FLUVASTATIN SODIUM | Teva | 2012 | 4 | Cardiovascular |
| LESCOL XL | Novartis | 2000 | 4 | Cardiovascular |
| PITAVASTATIN CALCIUM | SAWAI USA | 2016 | 2 | |
| LIVALO | KOWA CO | 2009 | 2 | |
| ZYPITAMAG | MEDICURE | 2017 | 1 | Metabolic |
| PRAVASTATIN SODIUM | SENORES PHARMS | 2006 | - | |
| ATORVASTATIN CALCIUM | LANNETT CO INC | 2011 | - |